RT X GEN Pharmaceutical Pvt. Ltd. is a successful division of RT Group of Companies established in the year 2019. Under the guidance of our Chairman,Mr. Suresh Yadav. We tremendously progressed and earned a spot in leading Ayurveda and Pharmaceutical company in Pune, India. Our company deals in Pharma marketing and Pharma manufacturing for multiple ALLOPATHY, AYURVEDIC, NUTRACEUTICALS, MEDICAL EQUIPMENTS and HEALTH & WELLNESS. With systematically organized contract manufacturing process that addresses the manufacture of high-quality products, we have captured the niche market segment in a very low time. A dedicated team that focuses on key international markets has leveraged our expertise in the manufacture of APIs and formulations to market various products successfully across the globe.
We seek to build a sustainable organizational ecosystem where one is constantly motivated to attain
new heights and empowered to discover new avenues
We develop and manufacture products with the Patient in the mind, ensuring we deliver the safest and most innovative products that have the highest performance with a continuous
To be recognized as pioneer and leader in the Field of healthcare by consistently ordering high quality medicines at most adordable price across India and globe for enhancing quality of life of human beings, Also a leading Ayurveda, Pharmaceutical and consumer product across the Globe all the way through concentrated Research and Development.
To be recognized as an emerging global Ayurveda and Pharmaceutical company by 2025 and make a strong presence in domestic market by ordering innovative, cost effective and quality products portfolio in targeted segments.
India is the world largest provider of generic medicines; the country’s generic drugs account for 20% of global generic drug exports (in terms of volumes). Indian drugs are exported to more than 200 countries in the world, with the U.S. as the key market.
Indian pharma companies ara capitalising on export oppurtunities in regulated and semi-regulated markets.
India’s public health expenditure has been steadily rising over the last decade in order to cater to its growing population. In fiscal year 2018, the value of public health expenditure by states and union territories together amounted to around 1.58 trillion Indian rupees. This was estimated to be around 1.28 % of the country’s GDP. In comparison, the United States’ budget estimates showed an outlay of over 17 % of the GDP to public health expenditure in its fiscal year 2018.
Govt. Expenditure on Health in India (US$ billion)